article thumbnail

NHS staff sign up to Covid-19 sniffer dog trial

The Pharma Data

Eleven hospitals across the UK are taking part in the study, with scientists hoping at least 3,500 staff will provide “odour samples” Testing has begun to see if medical detection dogs can be trained to smell the disease. If the trial is successful, the dogs could be used at UK airports to screen people arriving from abroad.

Trials 52
article thumbnail

The Definition of “Fully Vaccinated” Needs to Change

Eye on FDA

We are long gone from the days of being threatened by a rampant Alpha virus to having several successive variants. We have the emergence of monoclonal antibodies and protease inhibitors being utilized or being considered as treatments for various stages of disease. The COVID-19 pandemic is a rapidly changing landscape.

Vaccine 72
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Big Spike Seen in COVID Cases Among Kids

The Pharma Data

29, more than 853,000 children in the United States had tested positive for the virus since the pandemic began — 200,000 of them in October alone. “This virus is highly contagious, and as we see spikes in many communities, children are more likely to be infected, too. TUESDAY, Nov. In the week ending Oct.

Virus 52
article thumbnail

FDA Approves Emergency Use of Pfizer’s COVID Vaccine

The Pharma Data

. “The tireless work to develop a new vaccine to prevent this novel, serious and life-threatening disease in an expedited timeframe after its emergence is a true testament to scientific innovation and public-private collaboration worldwide.” Centers for Disease Control and Prevention advisory panel.

article thumbnail

Health Highlights: Dec. 28, 2020

The Pharma Data

Centers for Disease Control and Prevention said Saturday. The test is needed to guard against the spread of a new form of the virus found in the U.K. However, a new virus variant that has been spreading around London and southern England has now been spotted in France, Italy, Spain, Canada and Japan. © 2020 HealthDay.

Vaccine 52
article thumbnail

mRNA vaccines slash risk of COVID-19 infection by 91% in fully vaccinated people

The Pharma Data

People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study of eight sites, including Salt Lake City. Only 204 (5%) of the participants eventually tested positive for SARS-CoV-2, the virus that causes COVID-19.

Vaccine 52
article thumbnail

Deliberate Dysentery

Codon

Today, refined versions of these human challenge studies have become standard practice in testing vaccines for vector-borne diseases (e.g., yellow fever, malaria, and dengue), evaluating new drugs or treatments, and studying pathogenesis, the process by which a disease develops. How are disease targets selected for challenge trials?

Vaccine 132